A randomized trial posted Aug. 1, 2026, found that platelet-based injections outperformed a steroid shot for a painful, stiff shoulder over 12 months. For executives and other patients who pay out of pocket, the result is encouraging but small, and cost studies show the price of PRP varies by thousands of dollars.
By Alena Wiese
A business owner in Windermere may first notice it reaching for the top shelf of a closet, then on a backswing, then while trying to sleep on that side before an early flight. The shoulder aches and stiffens, and the calendar does not leave room for months of slow recovery. For someone used to paying for speed, a cash-pay platelet-rich plasma injection can sound like the efficient choice.
New research offers a more specific picture of what that choice may buy. A double-blinded, four-arm randomized controlled trial in the Journal of Orthopaedic Case Reports, posted Aug. 1, 2026, compared three platelet-based injections with a corticosteroid shot in 64 patients with periarthritis of the shoulder, 16 per group, followed for 12 months. At one year, pain scores on a 10-point scale averaged 1.6 with injectable platelet-rich fibrin, 1.8 with leukocyte-poor PRP and 2.1 with leukocyte-rich PRP, compared with 4.2 with triamcinolone, a common steroid. The between-group difference was statistically significant.
The direct answer: in this small trial, PRP-type injections were associated with better and longer-lasting shoulder results than a steroid injection. Money can buy access to that option. It cannot guarantee a result, and the price depends heavily on where and how PRP is prepared.
What did the new shoulder trial find?
The trial found that all three platelet preparations outperformed the steroid on pain and function at 12 months. Function was measured with the DASH questionnaire, where lower scores mean less disability. At 12 months, DASH scores averaged 15.0 with injectable platelet-rich fibrin, 16.8 with leukocyte-poor PRP and 19.2 with leukocyte-rich PRP, versus 37.4 with the steroid.
The authors, a team led by Aadithya Siddarth Sridhar and Madhan Jeyaraman, concluded that platelet concentrates, “particularly iPRF and LP-PRP, produced superior and sustained pain and functional benefit at 12 months with an excellent safety profile.” Each platelet injection used 5 to 6 milliliters, while the steroid arm received 40 milligrams of triamcinolone.
Source: Comparative Outcome Analysis of Leukocyte-Rich Platelet-rich Plasma, Leukocyte-Poor Platelet-rich Plasma, Injectable Platelet-rich Fibrin and Corticosteroid Injections in Periarthritis of the Shoulder: A Double-Blinded, Four-Arm Randomized Controlled Trial, Journal of Orthopaedic Case Reports, August 2026. https://jocr.co.in/wp/2026/08/comparative-outcome-analysis-of-leukocyte-rich-platelet-rich-plasma-leukocyte-poor-platelet-rich-plasma-injectable-platelet-rich-fibrin-and-corticosteroid-injections-in-periarthritis-of-the-shoulder/
How much does PRP cost, and who tends to get it?
Published prices vary widely, and PRP use tracks closely with income. A cross-sectional study in the Orthopaedic Journal of Sports Medicine, published online July 16, 2026, reviewed 3,667 knee osteoarthritis patients at two medical centers from 2022 to 2023 and reported PRP costs ranging from $175 to $4,973.
PRP recipients had a median income of $96,208, compared with $82,386 in the standard-care group, and upper-middle income was associated with nearly double the odds of receiving PRP (odds ratio 1.94). Patients at the Mayo Clinic Florida site were 2.19 times more likely to receive PRP. Recipients traveled a median of 62 miles for care, versus 31 miles for the comparison group.
Part of the price spread reflects how PRP is regulated. The FDA reviews PRP preparation systems as devices, and federal rules for human cell and tissue products exclude blood components. That leaves room for different kits, spin protocols and platelet counts, and for very different prices.
Source: Health Disparities in Orthobiologics: Factors Influencing Access to Platelet-Rich Plasma for Knee Osteoarthritis, Orthopaedic Journal of Sports Medicine, July 2026. https://journals.sagepub.com/doi/10.1177/23259671261458577
Does paying more make PRP work better?
One study found an association between higher out-of-pocket cost and better reported response, but it cannot show that price causes results. Researchers writing in PM&R, published online July 20, 2026, reviewed 209 first-time knee PRP injections in 199 patients at a tertiary orthopedic institution. Overall, 85 injections, or 41 percent, met the study’s definition of a responder at three to six months.
Each $500 increase in agreed-upon out-of-pocket cost was associated with higher odds of response (odds ratio 1.28). Having fewer than two lifestyle-related chronic diseases, such as hypertension, high cholesterol, type 2 diabetes or sleep apnea, was associated with about twice the odds of response (odds ratio 2.06). For a patient weighing a premium package, the second finding may be the more practical one: general metabolic health appeared to matter.
Source: Fewer lifestyle-related chronic diseases and higher out-of-pocket costs are predictive of favorable response to intra-articular platelet-rich plasma injections in the treatment of knee osteoarthritis, PM&R, July 2026. https://pubmed.ncbi.nlm.nih.gov/42473805/
What are the limits of this evidence?
The shoulder trial is promising but small. With 16 patients per group at a single center, it had limited power for comparisons between the three platelet preparations, and the authors note it lacked objective range-of-motion and imaging endpoints. It studied periarthritis of the shoulder, so the results do not automatically apply to knees, hips or tendons elsewhere.
The cost studies carry their own limits. The access study was cross-sectional and drew on two centers. The PM&R study was retrospective, with no placebo group, so the link between price and response could reflect expectations or other unmeasured factors. Guidance also differs by joint: the American College of Rheumatology’s 2026 osteoarthritis update strongly recommends against PRP for knee and hip osteoarthritis, a position the college rated as low-certainty evidence.
Where does an evaluation at a Hamlin clinic fit?
A sound plan starts with identifying what is actually driving the pain. ReliefNow® Disc Joint & Nerve Center Hamlin, at 5736 Hamlin Groves Trail, Suite 154, Winter Garden, serves patients from Hamlin, Horizon West, Winter Garden and Windermere. The practice lists Class IV laser therapy, DRX9000 spinal decompression, Piezowave shockwave, Knee-on-Trac knee decompression and PRP regenerative support, and its page states, “Every plan starts with an evaluation.”
Dr. Jeffrey N. Shebovsky, DC, who founded Orange Wellness in 1994 and holds Florida chiropractic license CH6499, brings more than 30 years of clinical experience and postgraduate training in sports injuries. For shoulder pain, an evaluation can help separate a stiff joint capsule from a rotator cuff problem or pain referred from the neck, and clarify whether conservative care is a reasonable first step.
Some findings call for prompt medical referral: sudden weakness after a fall, a hot swollen joint with fever, chest pressure or shortness of breath with left shoulder pain, or unexplained weight loss. Progress is best tracked with numbers, such as pain scores, measured range of motion and function questionnaires like the DASH used in the new trial, rechecked at set intervals.
What should a patient ask before paying?
The useful questions are specific. Which diagnosis is being treated, and what does the research show for that diagnosis? Which preparation will be used, how many injections are planned, and what is the total cost? How will improvement be measured, and when would the plan change?
For patients accustomed to evaluating major purchases carefully, the August trial is a reason for measured interest rather than a guarantee. PRP may belong in the conversation, weighed with the same discipline applied to any other significant investment.
About: Dr. Jeffrey N. Shebovsky, DC | ReliefNow® Disc Joint & Nerve Center Hamlin | 5736 Hamlin Groves Trail, Suite 154, Winter Garden, FL 34787 | 407-706-4944 | https://reliefnowlaser.com/providers/hamlin/
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any treatment program.
